UBS Group’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.76K | Buy |
2,670
+297
| +13% | +$974 | ﹤0.01% | 7602 |
|
|
2025
Q1 | $6.62K | Sell |
2,373
-42
| -2% | -$117 | ﹤0.01% | 7572 |
|
|
2024
Q4 | $41.7K | Buy |
2,415
+2,414
| +241,400% | +$41.7K | ﹤0.01% | 6189 |
|
|
2024
Q3 | $35 | Hold |
1
| – | – | ﹤0.01% | 8046 |
|
|
2024
Q2 | $54 | Sell |
1
-142
| -99% | -$7.67K | ﹤0.01% | 8061 |
|
|
2024
Q1 | $9.5K | Buy |
143
+138
| +2,760% | +$9.17K | ﹤0.01% | 6109 |
|
|
2023
Q4 | $574 | Sell |
5
-183
| -97% | -$21K | ﹤0.01% | 7366 |
|
|
2023
Q3 | $34.1K | Sell |
188
-18
| -9% | -$3.27K | ﹤0.01% | 5394 |
|
|
2023
Q2 | $75.4K | Sell |
206
-81
| -28% | -$29.6K | ﹤0.01% | 5162 |
|
|
2023
Q1 | $191K | Buy |
287
+230
| +404% | +$153K | ﹤0.01% | 4372 |
|
|
2022
Q4 | $50.3K | Buy |
57
+53
| +1,325% | +$46.7K | ﹤0.01% | 5617 |
|
|
2022
Q3 | $4K | Sell |
4
-82
| -95% | -$82K | ﹤0.01% | 8228 |
|
|
2022
Q2 | $72K | Sell |
86
-14
| -14% | -$11.7K | ﹤0.01% | 4660 |
|
|
2022
Q1 | $155K | Sell |
100
-125
| -56% | -$194K | ﹤0.01% | 4573 |
|
|
2021
Q4 | $404K | Buy |
225
+213
| +1,775% | +$382K | ﹤0.01% | 4141 |
|
|
2021
Q3 | $39K | Buy |
12
+2
| +20% | +$6.5K | ﹤0.01% | 5419 |
|
|
2021
Q2 | $44K | Sell |
10
-42
| -81% | -$185K | ﹤0.01% | 5478 |
|
|
2021
Q1 | $252K | Buy |
52
+38
| +271% | +$184K | ﹤0.01% | 4357 |
|
|
2020
Q4 | $26K | Sell |
14
-134
| -91% | -$249K | ﹤0.01% | 5733 |
|
|
2020
Q3 | $58K | Sell |
148
-183
| -55% | -$71.7K | ﹤0.01% | 4687 |
|
|
2020
Q2 | $101K | Buy |
331
+245
| +285% | +$74.8K | ﹤0.01% | 4476 |
|
|
2020
Q1 | $24K | Buy |
86
+69
| +406% | +$19.3K | ﹤0.01% | 5465 |
|
|
2019
Q4 | $12K | Buy |
+17
| New | +$12K | ﹤0.01% | 6102 |
|
|
2019
Q3 | – | Hold |
0
| – | -$1K | – | 6999 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6822 |
|